Monthly Archives: June 2022

Suicide is a leading cause of deathamong young people ages 20 to 24 in the United States, and the risk is even higher in individuals with type 1 diabetes. In fact, up to 7% of deaths in individuals with type 1 diabetes are a result of suicide. However, current screening tools for depression and suicide often miss individuals at risk of suicide and the risk among the type 1 diabetes patient population is greatly underestimated.

The symposium will highlight the work of RESCUE and address solutions for two distinct uncertainties faced by health care providers in the management of people with type 1 diabetes at risk of suicide: how to identify those at risk and the best way to prevent and reduce that risk.

Discussion topics will include:

"Suicide and self-harm are an all-too-common reality for young adults with type 1 diabetes, but it doesn't have to be. With a multi-pronged approach to awareness, education, and identification, we have the opportunity to intervene on the link between suicide and diabetes," said Professor Katharine Barnard-Kelly, PhD., RESCUE Collaborative Community. "With this symposium, it is our hope that we can reach stakeholders with awareness and arm them with messages that can ultimately save a young person's life if adopted in clinical practice and through mental health screenings."

Professor Katharine Barnard-Kelly, PhD and the RESCUE team will present during the symposium, Suicide and Self-InjuryUnveiling and Addressing the Hidden Nightmare in Diabeteson Friday, June 3 from 4:156:15 p.m. CT.

For more information, please contact the ADA Scientific Sessions media team onsite at the Ernest N. Morial Convention Center from June 37 by phone at 504-670-4902, or by email at [emailprotected].

About the ADA's Scientific SessionsThe ADA's 82nd Scientific Sessions, the world's largest scientific meeting focused on diabetes research, prevention, and care, will be a hybrid event held June 37, 2022 at the Ernest N. Morial Convention Center in New Orleans, LA. Leading physicians, scientists, and health care professionals from around the world will unveil cutting-edge research, treatment recommendations, and advances toward a cure for diabetes. We are eager to get back to safely participating in person and networking with colleagues while hearing the latest scientific advances and groundbreaking research presentations. Learn more and register atscientificsessions.diabetes.organd join the Scientific Sessions conversation on social media using #ADA2022.

About the American Diabetes AssociationThe American Diabetes Association (ADA) is the nation's leading voluntary health organization fighting to bend the curve on the diabetes epidemic and help people living with diabetes thrive. For 81 years, the ADA has driven discovery and research to treat, manage, and prevent diabetes while working relentlessly for a cure. Through advocacy, program development, and education we aim to improve the quality of life for the over 133 million Americans living with diabetes or prediabetes. Diabetes has brought us together, what we do next will make us Connected for Life. To learn more or to get involved, visit us atdiabetes.orgor call 1-800-DIABETES (1-800-342-2383). Join the fight with us on Facebook (American Diabetes Association), Spanish Facebook (Asociacin Americana de la Diabetes),LinkedIn (American Diabetes Association), Twitter (@AmDiabetesAssn), andInstagram (@AmDiabetesAssn).

SOURCE American Diabetes Association

Read more here:
American Diabetes Association Symposium to Bring to Light the Impact of Suicide and Depression on Adolescents with Type 1 Diabetes - PR Newswire

A commercial drivers license (CDL) is a drivers license necessary to operate trucks and drive interstate. Previously, people with diabetes may not have met the criteria to get a CDL. However, while a person needs to meet numerous health requirements, it is possible for those living with diabetes to become truck and bus drivers.

Prior to 2003, there was a ban on trucking for individuals with insulin-treated diabetes, both type 1 and type 2.

In 2003, the Federal Motor Carrier Safety Administration (FMCSA), the agency regulating the trucking industry in the United States, began a system known as the Diabetes Exemption Program. Through this lengthy process, a person with insulin-treated diabetes could obtain an exemption to operate large trucks.

However, in 2018, the FMCSA ended the program. Instead, a person living with diabetes can obtain a Medical Examiners Certificate (MEC), a standard certification other drivers need to provide to confirm they are physically able to operate a commercial vehicle.

An individuals treating clinician completes the assessment form attesting that they have a stable insulin regimen and properly controlled diabetes.

In this article, we discuss how a person with type 2 diabetes can pass their CDL, what it involves, and how long it is valid. We also suggest tips for driving with diabetes.

Following the new ruling by the FMCSA for people living with diabetes in 2018, a person with type 2 diabetes can obtain their CDL.

The new rule reflects modern diabetes management and means there is no longer a blanket exclusion against insulin use.

Previously, it was more difficult for people with insulin-treated diabetes to obtain their CDL. However, the new ruling supports that people with diabetes can safely operate commercial motor vehicles.

According to the new regulations, individuals with type 2 diabetes who do not require insulin only need to follow their state guidelines to obtain and keep a CDL.

If a person with type 2 diabetes requires insulin, they will now only need to obtain a MEC to confirm they have a stable insulin regimen and are able to manage their condition.

Under the new ruling, a listed certified medical examiner (CME) can grant a person with insulin-treated diabetes a MEC for up to 12 months.

To do so, the healthcare professional who manages and prescribes insulin for the person provides the assessment form to the CME. The CME will then determine if the person meets the FMCSAs qualification standards.

These standards include:

The assessment will also detail whether the person has recently experienced a severe hypoglycemic episode or any potential complications due to type 2 diabetes.

The FMCSA estimates that the annual cost to comply with this ruling is $332, which is significantly lower than the cost prior to the 2018 rule change.

The maximum period of medical certification under the new rule is 12 months. This new ruling is applicable in every state and U.S. territory.

To be eligible for the maximum 12 months, an individual needs to be able to provide sufficient evidence that they are able to manage their condition.

This includes being able to provide at least the preceding 3 months of blood glucose self-monitoring records. Without this, a CME may only be able to provide them a 3-month certificate to allow them to collect the necessary records.

Living with diabetes can affect a persons ability to drive, as they need to ensure their blood sugars are at suitable levels and may develop complications that may make it more difficult to drive.

Some tips for driving may include:

For individuals living with type 2 diabetes, it may be advisable to try the following:

Following the new ruling the FMCSA introduced in 2018, it is easier for people with type 2 diabetes to obtain a CDL. Individuals with insulin-treated diabetes need to obtain a MEC to operate commercial motor vehicles.

The FMCSA keeps a registry of CMEs. These healthcare professionals determine whether a driver meets the FMCSAs physical qualification standards to hold a CDL. This certification is valid for 12 months and enables a person to obtain a CDL.

Read the original here:
Can a person pass their CDL if they have type 2 diabetes? - Medical News Today